Cadila forays into US generics market

Nov 22 2013, 09:03 IST
Comments 0
Cadila Pharmaceuticals has launched the world’s first innovative drug treatment for lung cancer — Mycidac-C. Cadila Pharmaceuticals has launched the world’s first innovative drug treatment for lung cancer — Mycidac-C.
SummaryLaunches lung cancer drug at Rs 40k in India; same drug sells for over Rs 2 lakh globally.

to over 45 therapeutic areas including cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, anti-diabetics and immunologicals.

Single Page Format
Ads by Google

More from Corporates & Markets

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...